P036 Rechallenge Pemetrexed-Based Chemotherapy Provides an Option for Initially Benefitial Patients in Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.10.059
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Chemotherapy for Non-Small Cell Lung Cancer in Elderly Patients

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Rechallenge With First-Line Platinum Chemotherapy for Sensitive-Relapsed Small-Cell Lung Cancer

Case Reports in Oncology
Oncology
2018English

Predictive Factors of Severe Toxicities of Pemetrexed-Containing Chemotherapy in Patients With Non-Squamous Non-Small Cell Lung Cancer

Journal of Cancer Therapy
2017English

Salvage Lung Resection for Non-Small Cell Lung Cancer After Stereotactic Body Radiotherapy in Initially Operable Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2010English

Pemetrexed Versus Vinorelbine Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Elderly Patients

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer

BMJ
1994English

Novel Drug-Resistance Mechanisms of Pemetrexed-Treated Non-Small Cell Lung Cancer

Oncotarget
Oncology
2018English

Nursing Care for Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy: Evidence–based Implications for Practice

Canadian Oncology Nursing Journal
2008English

Preoperative Chemotherapy Improves Outcomes in Non-Small Cell Lung Cancer

BMJ
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy